TRAW

Conviction 0HealthcareScan · Mon, Aug 10, 2026

TRAW$0.5422+1.92%

ResistanceSupportVol 14Insider buy

Vol MA14 113.98K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Traws Pharma, Inc.PHARMACEUTICAL PREPARATIONSwww.trawspharma.com ↗

Price0.5422

Change+1.92%

Gap+3.35%

Rel volume0.07×

Avg volume115.55K

Avg $ vol63.69K

SMA 200.5530

SMA 500.8236

SMA 2001.60

Price vs 50-34.17%

Price vs 200-66.08%

MA stackbearish

50/200 cross—

Supertrenddown · 0.6180

RSI (14)40

MACD hist0.02

MACD cross—

Stoch %K / %D72 / 56

ADX (14)39

+DI / −DI18 / 30

RSI divergence—

MACD divergenceBullish

ATR %+10.57%

ADR %7.29%

52w high3.13

52w low0.4411

From 52w high-82.68%

Above 52w low+22.92%

New 52w highNo

SqueezeOff

Bollinger width53.52%

%B0.46

Donchian pos38.67%

Donchian high0.7200

Donchian low0.4301

AVWAP (52w high)1.99

vs AVWAP high-72.72%

AVWAP (52w low)0.5209

vs AVWAP low+4.08%

OBV trendDown

Chaikin MF (20)-0.32

Today vs 20d0.07×

Avg vol (14d)113.97K

Avg vol (20d)115.55K

Avg $ vol (20d)63.69K

Market cap8.21M

RS 3m (vs SPY)-74.40%

RS 6m (vs SPY)-83.18%

RS line new highNo

Trend template0/8

Technical rank4.0

1 week+14.97%

1 month-28.66%

3 months-75.13%

6 months-72.34%

1 year-63.36%

YTD-59.23%

P/E0.90

P/B0.71

P/S—

P/FCF-0.45

EPS0.8200

Div yield—

ROE79.23%

ROA112.43%

Debt/Eq—

Current0.43

EV/EBITDA0.69

Gross margin—

Net margin—

Rev growth—

EPS growth105.51%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-12.34M

Revenue57K

Net income-7.11M

Gross profit—

Free cash flow-18.2M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out—

Employees7

ListedThu, Jul 25, 2013

Free float4.96M

Float %62.1%

Short interest699.85K

Days to cover3.8d

Short volume28.3%

Squeeze score47 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank4.0 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance0.9194

Support0.4435

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in TRAW

All disclosures →

No recent disclosed trades by Congress in TRAW. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in TRAW · 10 buys

Insider	Side	Shares	Value	Traded	Filed
Pauza Charles David Chief Science Officer Virology · Stock Option (right to buy) · 2026-07-09	Grant	97K	—	2026-07-09	2026-07-16
CAUTREELS WERNER Director · Stock Option (right to buy) · 2026-07-09	Grant	14.15K	—	2026-07-09	2026-07-15
Savchuk Nikolay Chief Operating Officer · Stock Option (right to buy) · 2026-07-09	Grant	93K	—	2026-07-09	2026-07-15
OrbiMed Capital GP VIII LLC 10% owner · Series B Warrants (right to buy) · 2026-04-16	Buy	597.73K	—	2026-04-16	2026-04-28
ORBIMED ADVISORS LLC 10% owner · Series B Warrants (right to buy) · 2026-04-16	Buy	597.73K	—	2026-04-16	2026-04-28
OrbiMed Capital GP VIII LLC 10% owner · Series A Warrants (right to buy) · 2026-04-16	Buy	597.73K	—	2026-04-16	2026-04-28
ORBIMED ADVISORS LLC 10% owner · Series C Warrants (right to buy) · 2026-04-16	Buy	1.79M	—	2026-04-16	2026-04-28
OrbiMed Capital GP VIII LLC 10% owner · Common Stock · 2026-04-16	Buy	597.73K	$998K	2026-04-16	2026-04-28
ORBIMED ADVISORS LLC 10% owner · Series A Warrants (right to buy) · 2026-04-16	Buy	597.73K	—	2026-04-16	2026-04-28
OrbiMed Capital GP VIII LLC 10% owner · Series C Warrants (right to buy) · 2026-04-16	Buy	1.79M	—	2026-04-16	2026-04-28

SEC filings

EDGAR filings in TRAW · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.